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Abstract 
The Endosomal Sorting Complex Required for Transport (ESCRT) proteins form an evolutionarily conserved 
membrane remodelling machinery. Identified originally for their role in cargo sorting and remodelling of 
endosomal membranes during yeast vacuolar sorting, an extensive body of work now implicates a sub-complex 
of this machinery (ESCRT-III), as a transplantable membrane fission machinery that is dispatched to various 
cellular locations to achieve a topologically unique membrane separation. Surprisingly, several ESCRT-III-
regulated processes occur during cell division, when cells undergo a dramatic and co-ordinated remodelling of 
their membranes to allow the physical processes of division to occur. The ESCRT machinery functions in 
regeneration of the nuclear envelope during open mitosis and in the abscission phase of cytokinesis, where 
daughter cells are separated from each other in the last act of division. Roles for the ESCRT machinery in cell 
division are conserved as far back as Archaea, suggesting that the ancestral role of these proteins was as a 
membrane remodelling machinery that facilitated division and that was co-opted throughout evolution to 
perform a variety of other cell biological functions. Here, we will explore the function and regulation of the 
ESCRT machinery in cell division.   
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Introduction 
The Endosomal Sorting Complex Required for Transport (ESCRT) proteins form a series of multi-subunit protein 
complexes that assemble into a cargo sorting and membrane remodelling machinery [1,2]. Whilst initially discovered as 
regulators of cargo sorting on endosomes [3-5], it is becoming apparent that these complexes play essential and, until 
recently, relatively unappreciated roles in cell division [6-8]. The ESCRT machinery also plays essential roles in release 
of enveloped retroviruses and extracellular vesicles, in pruning neuronal processes, repairing both plasma and nuclear 
membranes and in regulating the quality of nuclear pore components (Figure 1) [9-11]. Despite this apparent breadth of 
functions, the processes controlled by the ESCRT machinery share a requirement for a specific membrane remodelling 
event for their completion; the separation of membranes that were previously connected by a cytoplasm-filled channel 
(Figure 1).  We will not discuss here these myriad cellular processes and refer readers to a series of excellent reviews in 
this volume. Rather, we will focus here on emerging roles for the ESCRT machinery in cell division, with emphasis on 
ESCRT-III-dependent mitotic membrane remodelling.  
Membrane and cytoskeletal remodelling events during division 
To allow cell division to proceed, cells must undergo a dramatic and complex restructuring of their membranes and of 
their cytoskeleton (Figure 2A). The examples given below relate largely to metazoan mitosis, although similar physical 
rearrangements occur during meiosis. During cell division, cells must dismantle and then reassemble their microtubule 
cytoskeleton to form a spindle that allows motor-driven segregation of their duplicated genome. Rearrangements of the 
microtubule cytoskeleton occur at mitotic onset in parallel with the separation and migration of centrosomes, which 
were duplicated alongside chromatids in S-phase, to opposing sides of the nucleus [12]. Mammalian cells undergo an 
open mitosis and mitotic commitment results in phosphorylation and disassembly of lamins, inner nuclear membrane 
proteins and chromatin associated factors such as Barrier-to-Autointegration Factor (BAF) and Histone H3. This 
breakdown allows disassembly of connections between the nuclear lamina and the nuclear envelope, a bi-layered 
organelle that is continuous with the endoplasmic reticulum (ER) [13,14]. Nuclear envelope disassembly is assisted by 
alterations in phospholipid synthesis that favour remodelling of this organelle and forces exerted by the cytoskeleton 
that enable its breakdown [13]. Nuclear envelope membrane proteins, including nuclear pore components that were 
similarly disassembled through mitotic phosphorylation, are released into the mitotic ER, and differential identity is lost 
between these organelles [13,14]. Growing spindle microtubules, now being assembled from microtubule 
polymerisation at opposing centrosomes, latch onto mitotic kinetochores with amphitelic attachments ensuring bi-
orientation at the metaphase plate [12]. The plus-ends of spindle microtubules that don’t engage kinetochores 
interdigitate at the centre of the cell, forming the characteristic diamond-shaped spindle. Satisfaction of the spindle 
assembly checkpoint (SAC) permits motor driven segregation of sister chromatids [12] and marks the onset of mitotic 
exit. During late anaphase and progress into telophase, an acto-myosin rich cleavage furrow ingresses between forming 
daughter cells, constricting the plasma membrane and, together with the action of bundling proteins such as Protein 
Regulator of Cytokinesis-1, condense the spindle into a tight bundle of microtubules that will form a structure called a 
midbody [15]. Concomitantly, sheets of mitotic ER are deposited upon the chromatin through interaction of chromatin 
binding proteins such as Heterochromatin Protein-1 and Barrier to Autointergration Factor (BAF), with the Lamin-B 
receptor and LEM-domain containing family of inner nuclear membrane (INM) proteins including MAN1 and Lamina-
associated polypeptide 2 (LAP2. Interaction of the nucleoporins ELYS/MEL-28, NDC1 and POM121 with 
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chromatin can also assist ER-deposition [16,17]. ER-sheets enveloping the now-decondensing chromatin are sealed 
through the process of annular fusion to allow regeneration of the nucleus through Nuclear Pore Complex (NPC)-driven 
re-compartmentalisation and subsequent re-establishment of separate nuclear envelope and ER identities [18,19] (Figure 
2A and 2B). Alongside reconstruction of the nuclear envelope, acto-myosin-driven ingression of the cleavage furrow 
and formation of the midbody, the chromatin fully decondenses and the cell prepares for separation of its cytoplasm 
through the process of cytokinesis. During this process, the tubulin-rich midbodies are progressively thinned through 
removal of microtubules, leaving daughter cells tethered by a thin tube of membrane. This membrane is severed through 
the process of cytokinesis, resulting in two functional daughter cells [8,20] (Figure 2A and 2B). Importantly, the 
topology of membrane fission required for sealing holes in the nuclear envelope (annular fusion) and cytokinesis are 
identical (Figure 2B). 
Whilst the above description describes the situation in metazoans, related remodelling events occur in all organisms. 
However, key players and necessary physical processes can differ markedly. For example, yeast such as S. cerevisiae or 
S. pombe undergo a closed mitosis, assembling an intra-nuclear spindle without breaking open their nuclear envelopes 
[21]. S. japonicus, a fission yeast strain related to S. pombe undergoes a semi-open mitosis and provides an important 
comparative evolutionary model for analysis of mitotic programmes [22,23]. Whilst we will discuss below the role of 
the ESCRT machinery in metazoan mitotic events, it is important to note that many mitotic phenotypes described have 
not been observed in yeast, and this may reflect the engagement of distinct mitotic programmes in these organisms and 
the circumvention of the ESCRT machinery by fungal-specific processes such as synthesis of a chitin-rich cell wall that 
participates in cleavage furrow ingression and cytokinesis. Roles for the ESCRT machinery (specifically the ESCRT-
III complex) in division have, however, been observed in Archaea [24,25], organisms separated from humans by over 
2.5 billion years of evolution and devoid of internal membranes. These findings suggest that the ancestral role for the 
ESCRT machinery is in cell division, and that these proteins have been co-opted throughout evolution to perform a 
series of topologically related membrane remodelling events that allowed the development of multicellular organisms, 
and facilitated cellular exploitation by pathogens.  
The ESCRT machinery – a subdivision of labour 
Whilst not the goal of this review, it is perhaps helpful to introduce the individual complexes and subdivision of activities 
within the ESCRT machinery. In the context of endosomal sorting, and learning from examples described in yeast, the 
ESCRT machinery performs both cargo sorting and membrane remodelling functions. There exist 4 ESCRT complexes 
(Table 1; ESCRT-0, ESCRT-I, ESCRT-II and ESCRT-III) and a variety of accessory proteins that assist ESCRT 
function. ESCRT-I is a rod-shaped heterotetrameric complex [26] that interacts with a variety of adaptor proteins to 
localise this machinery to subcellular localisations [27,28]. ESCRT-II is a Y-shaped hetrotetramer formed from a 1:2:1 
complex of Vps22/EAP20, Vps25/EAP30 and Vps36/EAP45 that links ESCRT-I to ESCRT-III [29-33]. ESCRT-I and 
ESCRT-II contain ubiquitin-binding domains [34-37] that participate in the transfer of ubiquitinated cargo onto nascent 
intraluminal vesicles. These complexes act at the bud neck of invaginating vesicles [38] and are localised to endosomal 
membranes through interaction with a 4th ubiquitinated-cargo binding complex, post-hoc christened ESCRT-0 [1,2]. 
ESCRT-0 is a complex of Vps27 and Hse1 (and of Hepatocyte Growth Factor Regulated Tyrosine Kinase Substrate 
(HRS) and Signal Transducing Adaptor Molecule (STAM)-1 and 2 in mammalian cells). A PtdIns(3)P-binding FYVE 
(Fab1, YOTB, Vac1, EEA1) domain in Vps27/HRS localises ESCRT-0, and thus the entire machinery, to PtdIns(3)P-
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rich endosomes [2,39,40]. Vps27/HRS and Hse1/STAM both contain ubiqitin-binding Vps27, HRS and STAM (VHS) 
domains and additional uniquitin-interacting motifs (UIMs), highlighting ESCRT-0 as a critical endosomal ubiquitin 
cargo receptor [41]. In yeast, an interaction between Vps28 in ESCRT-I and an insertion in the ubiquitin-binding GLUE 
(GRAM-like Ubiquitin-binding in EAP45) domain of Vps36 forms a PtdIns(3)P binding split-PH domain that recruits 
this complex to membranes [32]. The situation in mammalian cells is a little less clear, but a 3-phosphoinositide-binding 
GLUE domain within VPS36 may play a similar role [36]. ESCRT-II can bind directly to the Vps20/CHMP6 subunit of 
ESCRT-III, and so links upstream ESCRT activity with the proposed membrane remodelling complex. It should be 
noted, however, that whilst ESCRT-II plays essential functions in Multivesicular Body (MVB) sorting in yeast [4,42], 
roles for ESCRT-II in mammalian cells have been a little confusing, with links between ESCRT-I and ESCRT-III 
suggested to be provided by adaptor proteins such as ALG-2-Interacting Protein X (ALIX) [43-46] and Histidine-
Domain Protein Tyrosine Phosphatase (HD-PTP) [47-49], both of whom bind directly to the ESCRT-I component 
Tumour Susceptibility Gene-101 (TSG101) and filament-forming subunits of ESCRT-III [50]. ESCRT-II has been 
found dispensable for Human Immunodeficiency Virus-1 (HIV-1) release and endosomal sorting [51,52]. However, 
recent data suggest an alternative explanation in that ESCRT-II behaves as an assistive linker between ESCRT-I and –
III during cytokinesis [53,54] and viral release [55,56], suggesting that cells have evolved parallel mechanisms to recruit 
ESCRT-III.  ESCRT-III itself comprises a polymer of small self-assembling proteins, which in mammalian cells are 
known as CHMPs (Charged Multivesicular Body Proteins/Chromatin Remodelling Proteins) and the CHMP-like 
protein, Increased Sodium Tolerance-1 (IST1) [2,5,57,58]. CHMPs contain 5, or sometimes 6, recognisable alpha helices 
and exist in soluble or filament forming conformations. Transition between states is regulated by displacement of a C-
terminal regulatory helix which is thought to drive assembly and membrane remodelling [42,59-61]. Notably, roles for 
ESCRT-III proteins in Archaea division was described in strains lacking FtsZ or Mre1, the prototypical actin and tubulin 
paralogues, suggesting that ESCRT-III may represent an ancestral filament forming machinery that may function in 
place of these cytoskeletal members [24,62].  
CHMPs polymerise into spiral filaments on membranes [63-66] and it is thought that these spirals assemble within the 
membranous stalks described in Figure 1. ESCRT-III activity is predicted to result in severing of these stalks and 
separation of the previously joined membranes, permitting vesicle, viral, cell, or nuclear membrane separation [1,6]. 
Notably, ESCRT-III proteins contain C-terminal peptide stretches called MIT-domain Interaction Motifs (MIMs) that 
engage the Microtubule Interaction and Trafficking (MIT)-domain of an evolutionarily conserved AAA-ATPase called 
VPS4 [67-69]. VPS4 represents the sole energy consuming element of this pathway and is necessary for recycling and 
disassembling ESCRT-III filaments. The exact mechanism of ESCRT-III dependent membrane separation remains a 
matter of intense debate; in recent years the discovery that ESCRT-III spirals force individual CHMP subunits to adopt 
energetically unfavourable conformations has allowed the proposal that these spiral filaments form an elastic spring that 
can store energy and later release it for membrane deformation, or indeed, scission [65,66,70]. Likewise, ATP 
consumption by VPS4 has been suggested to both disassemble [71] and remodel [72] the ESCRT-III filament, which 
may contribute toward its activity in membrane fission.  A variety of suggestions for VPS4-dependent regulation of 
ESCRT-III have been proposed, culminating in biophysical models such as ‘dome [73]’, ‘whorl [33]’ or ‘reverse dome 
[1]’ whereby progressive constriction of an ESCRT-III filament, capped by a dome-shaped subcomplex of 
CHMP2/CHMP3 is thought to lower the energetic barrier of severing the membranous stalk and achieving membrane 
fission [73]. Alternate models, such as the buckling model proposed by Hurley [1], attempt to reconcile observations 
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that are inconsistent with the dome models (namely that in a variety of systems, ESCRT-III filament growth is outward, 
rather than constrictive [66]) and attempts to integrate hypotheses concerning the elastic nature of these filaments. In 
these models, radial growth of the filament allows the accumulation of energy at unfavourable curvatures which, upon 
breaching some elastic limit, is released to ‘buckle’ and sever the membrane.  
As well as core ESCRT-III subunits, evidence is emerging that polymerisation of ESCRT-III may be controlled through 
the engagement of regulatory Coiled-Coil and C2-domain containing 1A/1B proteins (CC2D1A/CC2D1B; Lethal Giant 
Discs, (Lgd) in D. melanogaster). These proteins bind specifically to the Shrub/CHMP4 N-terminus proteins through 
their third DM14 domain [74,75]. In mammalian cells, this interaction acts to suppress ESCRT-III dependent function, 
for example, during HIV-1 release [74,76], whereas in flys, Lgd has been suggested as a positive regulator of ESCRT-
III function during endosomal sorting [77] and abscission [78]. Interestingly, crystal structures of the D. melanogaster 
CHMP4 orthologue (Shrub) showed that these proteins polymerise in a head-to-head orientation, with salt bridges and 
complementary inter-subunit electrostatic interactions driving filament assembly [79] (although in yeast, analogous 
inter-subunit interactions were supported by hydrophobic, rather than electrostatic contacts [80]). Interestingly, the 
polymerisation surface in Shrub is also the Lgd-binding surface, and the crystal structure of a Lgd-DM14-3/Shrub core 
fusion demonstrated that Shrub occluded the polymerisation surface, suggesting that these proteins act as allosteric 
inhibitors of ESCRT-III polymerisation [75]. A similar situation is thought to occur with mammalian proteins, whereby 
CC2D1A suppresses CHMP4 polymerisation through analogous interactions [74]. CC2D1A/CC2D1B orthologues are 
absent from yeast, suggesting that acquisition of this electrostatic polymerisation interface, and the ability to control 
filament assembly through these regulatory proteins, represents an evolutionary adaptation of this pathway as cells 
gained complexity. It should be noted that if these proteins do act as negative regulators of ESCRT-III polymerisation, 
then their absence may lead to inappropriate ESCRT-III polymerisation, which may explain the conflicting reports as to 
whether these proteins positively or negatively regulate ESCRT-III function. 
Adaptors for localising ESCRT-III 
The exact mechanism by which membranous stalks are severed and membranes separated awaits experimental 
validation, however, it is clear that ESCRT-III is the main driver of this process. In a cell biological context, this 
machinery is recruited to distinct sites of action through interaction with a variety of adaptor proteins [6,11]. In the 
context of viral release, Late-domains (L-domains) within various viral structural proteins have evolved to bind directly 
to ESCRT-I and accessory proteins. For example, the primary L-domain of HIV-1, a PTAP motif within Gag-P6, mimics 
the TSG101-binding motif (PSAP) within HRS and directly binds TSG101’s UEV domain. HIV-1 also contains an 
auxiliary L-domain, an LYPxL motif within Gag-P6, that binds the ESCRT-III adaptor protein ALIX [2,81]. In this way, 
enveloped retroviruses recruit the ESCRT-III machinery to budding sites to facilitate their cellular egress and the 
evolution of auxiliary L-domains ensures robust recruitment of this machinery. For membrane repair, ALG2 is necessary 
for recruitment of this machinery to the plasma membrane [82,83]. In the context of cytokinesis, a specialised midbody 
protein, Centrosomal Protein of 55 kDa (CEP55), makes direct interactions with TSG101 and ALIX to facilitate 
recruitment of ESCRT-III to this structure (Figure 2C) [45,46,84,85]. The ESCRT machinery thus represents a 
transplantable membrane remodelling complex that is targeted to a variety of subcellular localisations through 
interaction with distinct adaptor proteins to enable an ESCRT-III-catalysed membrane separation.  
ESCRT-dependent regulation of cytokinetic abscission 
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In the final stages of cytokinesis, the midbody (a membrane and microtubule-rich intercellular bridge connecting 
daughter cells) is severed through the process of abscission. This process bears a topological equivalence to the 
membrane separation events performed by ESCRT-III (Figure 1 and Figure 2B). A centralspindlin-interacting protein, 
CEP55, plays an essential role in coordinating a machinery able to perform cytokinetic abscission [86,87]. The midbody 
contains a number of geographical zones, well described by [88], and we refer to the midbody as the entire intercellular 
bridge and the central ‘dark zone’ as the Flemming body. CEP55 localises to centrosomes in interphase and during early 
mitosis [86,87,89] and later transitions to the Flemming body during mitotic exit. Whilst data initially suggested that 
Polo-like Kinase-1 (PLK1) was a positive regulator of this CEP55 dependent recruitment [86,89], more recent data 
indicates that PLK1 phosphorylation of CEP55 prevents it from both interacting with the central spindle and being 
prematurely recruited to the midbody. CEP55 translocation to the Flemming body is permitted as PLK1 is degraded 
during mitotic exit [90].  CEP55 directly binds two ESCRT components through interaction with conserved GPP motifs 
in both ALIX and TSG101 [45,46,84]. Intriguingly, ALIX and TSG101 compete for the same site in the hinge region of 
CEP55 [85], suggesting that, just as many viruses employ primary and auxiliary L-domains [28], robust mechanisms 
exist to ensure proper recruitment of the ESCRT machinery by CEP55. ALIX’s BroI domain makes direct contact with 
the C-termini of the CHMP4 subunits of ESCRT-III and, in HeLa cells, this axis is essential for proper completion of 
cell division [45,46,50]. ALIX itself is subject to phospho-regulation, with mitotic phosphorylation of residues in 
ALIX’s C-terminal Proline-Rich Region causing a conformational change that triggers interaction with CHMP4 proteins 
and cytokinetic abscission [91]. These data suggest that phosphorylation of ESCRTs can be a trigger for coordinating 
recruitment and activity of these complexes during mitosis. 
Whilst ALIX seems the major adaptor for cytokinesis in HeLa cells, the existence of ESCRT-II dependent cytokinesis 
routes that are exposed in the absence of an ALIX:ESCRT-III interaction highlight the robustness of this axis for the 
completion of cell division [53]. In both cases, direct recruitment by CEP55:ALIX:CHMP4 or indirect recruitment 
through a TSG101:ESCRT-II:CHMP6 route, the placement of ESCRT-III at the midbody is thought to catalyse the final 
membrane separation [92,93]. In addition to the core members, whilst dispensable for MVB sorting and HIV-1 release, 
mammalian IST1 plays an essential role in abscission [94,95], indicating that process-specific ESCRT-III complexes 
are assembled. Additional ESCRT-III requirements specific for abscission have been exposed through the discovery that 
the MIT-domain containing protein, Microtubule Interacting and Trafficking Domain Containing 1 (MITD1), interacts 
with ESCRT-III through binding CHMP1A, CHMP1B, CHMP2A and IST1, and is necessary for abscission [96,97]. 
MITD1 contains a membrane-binding Phospholipase-D-like fold and the ability of MITD1 to bind membranes through 
this domain was essential for abscission [96], suggesting that this protein may function as an ESCRT-III-membrane 
tether during abscission. In the case of cytokinetic abscission, the membrane remodelling activity of ESCRT-III is 
necessarily coordinated with localised disassembly of microtubules in the midbody. To effect this, the MIT-domain 
containing AAA-ATPase, Spastin, is recruited to the midbody through coordination of MIMs in ESCRT-III subunits 
such as CHMP1B [98,99] and provides an activity essential for microtubule clearance and cytokinetic abscission. In this 
manner, ESCRT-III coordinates membrane and cytoskeletal remodelling events essential for the completion of cell 
division (Figure 2C).   
Dynamic nature of ESCRT-III at the abscission site 
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Excitingly, using state of the art electron tomography, spiral filaments have been visualised at the abscission site that 
may correspond to filaments of ESCRT-III [92]. Whilst the existence of these filaments was ESCRT-III [92] and VPS4 
[72] dependent, their 17 nm diameter is at odds with observed sizes for homomeric ESCRT-III filaments. However, it 
is possible that these thicker filaments represent ESCRT-III in-toto – a situation that has not yet been achievable in-
vitro. Indeed, co-polymers of CHMP1B and the N-terminal domain of IST1 have recently been described, that result in 
24 nm diameter filaments [100]. However, definitive proof that these cytokinetic filaments are indeed ESCRT-III spirals 
awaits experimental validation. Building on these results, and the recent demonstration from the Roux lab that ESCRT-
III filaments behave like elastic springs, using elastic potential energy from filament assembly to remodel the membrane 
[66], Gerlich, Roux and colleagues [72] have recently discovered that cytokinetic ESCRT-III filaments are more 
dynamic than previously thought. Using high-resolution microscopy and photobleaching approaches, they discovered 
that subunit exchange occurs between cytoplasmic and membrane-bound, midbody-assembled pools of CHMPs, with 
filament makeup turning over almost completely during residency at the midbody. These data indicate that the ESCRT-
III filament is actively remodelled as cells progress through cytokinesis. Recruitment kinetics for ESCRT-III members 
(CHMP2B, CHMP3 and CHMP4B) were indistinguishable, with these subunits being recruited gradually over the 40 
minutes prior to abscission, suggesting that co-polymeric filaments assemble during cytokinesis. Dynamic subunit 
exchange was dependent upon VPS4’s ATPase activity and VPS4 itself was necessary for midbody constriction, 
suggesting that dynamic subunit remodelling creates the force necessary to bring the membranes together for abscission 
[72].  
Filament remodelling and subunit exchange could also be observed in-vitro, using purified yeast proteins, and here, the 
authors observed that Vps24 and Vps2 could suppress Snf7 polymerisation, suggesting that these subunits act to regulate 
assembly of the membrane remodelling filament. However, rather than acting as a ‘cap’ to the growing Snf7 spiral, as 
has been previously proposed [59], these proteins polymerised alongside Snf7 spirals and appeared to bundle the Snf7 
filaments into a disc like morphology that suppressed further Snf7 growth [72]. Again, Vps4 remodelled these filaments 
to allow further Snf7 polymerisation. Thus, one exciting new role for Vps4 that this study exposes is its function as a 
quality control mechanism, disassembling non-productive filament assembly and removing the brake that Vps2/Vps24 
filaments seem to impose on Snf7 filament growth. These data have profound implications for our understanding of how 
the ESCRT-III filament behaves, both during cytokinesis and in all other ESCRT-III-dependent processes. Moreover, 
these data suggest that VPS4 plays an active role in constriction and filament remodelling rather than the disassembly 
role most often ascribed to it.  If it is possible to remove and replace subunits from within a pre-existing filament, what 
effect does this have on the rigidity or force imposing properties of these filaments? Does subunit exchange allow for 
filament remodelling to better match the geometric constraints of the membrane environment being remodelled? 
Maturation of the midbody 
During cytokinesis, progression from midbody formation to abscission takes upwards of an hour (in cultured HeLa 
cells), rendering abscission a G1 event [101]. During this time, midbodies become thinner and undergo a series of poorly 
understood morphological changes deemed ‘maturation’, until the signal to complete cytokinesis is triggered. In some 
cell types, for example, Germline Stem Cells (GSCs), abscission can be delayed for many hours and occurs well after 
mitosis completes [102,103]. Just as live cell imaging revealed the transient appearance of ESCRT-III members 
immediately prior to virion release [104,105], the peak of ESCRT-III components at the midbody occurs just prior to 
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cell separation [72,92,93,106]. Interestingly, the initial localisation of ESCRT-III subunits appears to be to two rings on 
each side of the Flemming body, but this does not represent the actual cut site. The site of abscission is specified 
approximately 1 micron along the midbody arms at a thinning, or secondary ingression, where the midbody diameter is 
reduced from circa 1 m to 0.1-0.2 m, which may be a more geometrically appropriate structure for ESCRT-III to act 
on (Figure 3). How ESCRT-III transitions from the initial assembly site to the cut site remains unclear – whether a spiral 
filament extends this distance, or whether a discrete secondary filament is formed awaits experimental validation [93].  
Progressive removal of tubulin filaments by microtubule-severing ATPases such as Spastin [98,99], is likely to facilitate 
midbody thinning, but is unlikely to account fully for the delay in abscission initiation as the secondary ingression and 
localised removal of tubulin for abscission occurs in a narrow zone within a still-tubulin-positive midbody. Whether two 
distinct tubulin remodelling events (thinning and local removal) are required for abscission remains unknown. In the 
case of migratory cells with room to spread, a lengthening of the midbody is also observed, and, as discussed below, 
this can influence the timing of abscission [107,108].  
As well as reorganisation of the microtubule cytoskeleton, the actin cytoskeleton must also be remodelled. F-actin plays 
a critical role in cleavage furrow ingression and has been observed to persist in the furrow until the time of abscission 
[109]. However, it has been unclear how actin is removed from the abscission site to enable abscission to proceed. 
Formation of the secondary ingression itself requires actin remodelling [110], suggesting that the actin cytoskeleton 
plays important roles in templating the sub-midbody structure to facilitate membrane abscission. Endosomal delivery of 
the actin remodelling protein p50RhoGAP and the Secretory Carrier-Associated Membrane Protein 2/3 (SCAMP2/3) 
transmembrane proteins, via Rab11 Family-Interacting Protein-3 (FIP3)-positive endosomes [110], are necessary to 
create the secondary ingression [110].  In addition, Rab35 [111], Occulo-Cerebro-Renal  syndrome of Lowe (OCRL) 
[112] and Molecule Interacting with CasL-1 (MICAL1) [113] have been shown to participate in removal of cortical F-
actin from the midbody, so facilitating abscission. MICAL1 is a monoxygenase that contributes to actin disassembly 
through direct oxidation of methionine residues on actin [114]. Echard and colleagues have recently discovered that F-
actin accumulation in the midbody prevents CHMP4B-recruitment and that MICAL1 is recruited to, and activated at, 
midbodies through direct interaction with GTP-Rab35 [113]. In this manner, MICAL1 helps depolymerise F-actin, 
clearing the way for ESCRT-III assembly at the abscission site (Figure 3). 
Alongside changes to the actin and microtubule cytoskeletons, the plasma membrane also gets remodelled during 
cytokinesis. The plasma membrane lipid PtdIns(4,5)P2 plays an important role in cytokinesis [115-117] and cortical 
actin remodelling [118]. As well as participating in actin-removal, ORCL-dependent dephosphorylation of PtdIns(4,5)P2 
[112,119] is thought to contribute to cytokinesis progression, although whether its activity remains focussed at the 
midbody [112], or whether endosomal PtdIns(4,5)P2-dephosphorylation elevates the relative cytokinetic pool of this 
lipid [119] remains a matter of ongoing investigation. Other links between actin and plasma membrane remodelling 
include SCAMP3, which was necessary for actin remodelling, but can bind the ESCRT components HRS and TSG101 
[120] and could thus play a role in stabilising these proteins at the midbody. Whilst HRS is most known for coordinating 
ESCRT-assembly on endosomes through its PtdIns(3)P-binding, FYVE domain, recent studies have also detected a 
midbody pool of PtdIns(3)P that recruited the FYVE-domain containing protein, FYVE-CENT to assist abscission [121]. 
In this light, reports of Class III PI 3-kinase dependent abscission [122] suggest that 3’-phosphorylated phosphoinositides 
may also contribute to midbody remodelling.  
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As such, an interplay between actin and microtubule cytoskeletons, and plasma membrane lipids, underlies the process 
of midbody maturation (Figure 3). We believe that this remodelling acts as a molecular timer to delay engagement of 
the abscission machinery until the cell is ready to irreversibly split. 
Checkpoint control of abscission timing 
Mitosis follows a temporally coordinated unidirectional programme, with progression between sequential phases being 
rapid but with a series of control points inserted to ensure progression occurs only when subsequent stages have been 
performed satisfactorily. The major control point in mitosis, the SAC, delays anaphase onset until bi-orientation of sister 
chromatids is achieved. However, in recent years, an additional control point has been identified during the final stages 
of cytokinesis – the abscission checkpoint. This checkpoint is thought to allow the cell to resolve any post-SAC defects 
accompanying chromosome segregation, and appears to exploit the natural control mechanisms governing abscission 
timing and midbody maturation.  
The existence of such a checkpoint was described first in yeast that exhibited an abscission delay in response to anaphase 
defects. This delay, deemed a control mechanism called NoCut, was shown to depend upon Aurora/Ipl1 in the spindle 
midzone and the presence of chromatin in the cleavage plane [123,124]. Chromosome breakage was observed in the 
absence of NoCut, suggesting that it represents an adaptive response to chromosome segregation errors [123]. Similar 
checkpoint behaviour was observed in mammalian cells, where an Aurora B-mediated abscission checkpoint was 
activated in the presence of lagging chromosomes and acted to delay abscission to facilitate proper chromosome-
segregation [109]. Sustained Aurora B activity, localised to the chromosome bridge, was revealed as the source of this 
abscission delay, suggesting the existence of Aurora B substrates that act to effect this checkpoint [109] (Figure 4). 
Whilst the Aurora B-dependent cytokinesis checkpoint is activated in response to mitotic defects, this kinase also 
imposes temporal control in the context of normal cytokinesis [109]. This is particularly evident in GSCs, where 
cytokinesis is substantially delayed, leaving cells connected for extended periods by an inter-cellular bridge [103]. In D. 
melanogaster GSCs, ALIX and ESCRT-III are necessary for abscission [78,125] and recruitment of CHMP4B/Shrub to 
the site of abscission occurs nearly 10 hours after mitosis, suggesting the existence of regulatory networks that suppress 
untimely assembly of this machinery [102]. Aurora B appears part of this network and acts to prevent precocious 
abscission in these cells [102], likely by negatively regulating Shrub-dependent abscission [78]. Indeed, disruption of 
Aurora B advanced abscission in these cells in a manner that could be rescued by constitutively active Cyclin B [126]. 
In mammalian cells, Cyclin B2 localised to the midbody and positively regulated abscission [126], suggesting that these 
kinases may act together as a molecular timer regulating abscission timing. 
In addition to Aurora B- and ESCRT-III-dependent control of abscission timing, it also appears that regulation of actin 
remodelling can contribute to this process. As described above, actin must be cleared from the midbody to allow 
cytokinesis to proceed [110,113]. In cells in which the abscission checkpoint is engaged (for example, those bearing a 
lagging chromosome), actin persists in the furrow and accumulates at patches proximal to the midbody until the mis-
segregating chromosome is resolved [109]. In GSCs, a secondary actin ring contributes to the abscission delay that 
maintains the intercellular bridge in these cells [102]. Although we know relatively little about how this regulation 
occurs, the actin cytoskeleton’s role in regulating midbody maturation and the progress to abscission appears integrated 
into the abscission checkpoint.  
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Molecular regulators of the abscission checkpoint 
Whilst Aurora B may regulate abscission timing, the mechanistic basis for this is only recently coming to light. One 
Aurora B substrate has been revealed to be the ESCRT-III subunit, CHMP4C [106,127]. CHMP4C is related to the 
major filament-forming CHMP4B subunit of ESCRT-III, although protein copy-number analysis suggests that it is 
expressed at 10-fold lower levels [128]. CHMP4C-depletion produces accelerated abscission, suggesting that, like 
Aurora B [102,109,126], this protein contributes to a regulatory delay in  normal cytokinesis that allows proper midbody 
maturation [106]. CHMP4C is preferentially recruited to the midbody through the CEP55-ALIX route, rather than the 
CEP55:TSG101:ESCRT-II route [53], and contains a C-terminal insertion containing residues that can be 
phosphorylated by Aurora B, suggesting that it may be a CHMP4 paralogue that has evolved to accept Aurora B-
mediated control. Whilst S210 represents the major phospho-acceptor [106], S214 and S215 also receive Aurora B-
dependent phosphorylation [127]. Overexpression of CHMP4C (either WT [106,127], phosphomimic, or 
phosphomutant forms [127]) impairs abscission. Cells reliant upon versions of CHMP4C unable to accept Aurora B 
phosphorylation display premature abscission, even in the presence of mis-segregating chromatin, suggesting that 
Aurora B-phosphorylated CHMP4C retards abscission [106] (Figure 4).  
The mechanism by which CHMP4C delays abscission is a matter of ongoing investigation; CHMP4C localises early in 
cytokinesis and occupies the Flemming body [106], whereas CHMP4B decorates the midbody arms [93,106]. RNA-
interference and rescue experiments employing phosphorylation-defective forms of CHMP4C suggest that Aurora B-
mediated phosphorylation of CHMP4C prevents it migrating from the central region of the midbody to the midbody 
arms to trigger abscission [106]. Indeed, geographical segregation of abscission components within the midbody has 
been suggested as a mechanism through which abscission timing is regulated through other effectors too. A Flemming-
body localised NoCut regulator called ANCHR (Abscission/NoCut Checkpoint Regulator) binds VPS4 through a MIM1 
motif and retains VPS4 in the Flemming-body, preventing it from transitioning to the site of abscission [129]. In this 
way, the abscission checkpoint is effected through spatio-temporal control over ESCRT-III assembly and abscission 
(Figure 4).  
However, there are alternate explanations for the mechanistic basis of CHMP4C-dependent abscission control; the 
Chromosomal Passenger Complex component Borealin binds directly to CHMP4C’s N-terminus [127] and it has been 
proposed that this interaction impairs CHMP4C’s membrane remodelling activity, as evidenced by atomic force 
microscopy-visualised remodelling of bilayers in-vitro by CHMP4C [130]. These studies also revealed the presence of 
S210-phosphorylated CHMP4C in the spindle midzone and restricted to the Flemming body, whereas a S210/S214/S215 
tri-phosphorylated signal decorated the midbody arms, suggesting a complex pattern of CHMP4C phosphorylation 
occurs during abscission progression and that phosphorylation may govern the geographical distribution of CHMP4C 
within the midbody [130]. Indeed, Aurora B-independent phosphorylation of CHMP4C has been reported during mitosis 
[108], and the identity of kinases involved in phosphorylation of, and functional roles for these phosphorylations on, 
this critical ESCRT-III subunit await identification.  
The ESCRT machinery has evolved to include additional members that help regulate this checkpoint; the Unc51-like 
kinase3 (ULK3) can bind MIM-containing ESCRT-III components via tandem MIT-domains and phosphorylates these 
proteins [108]. Similarly to CHMP4C, ULK3 depletion accelerates normal abscission and blunts the response to 
abscission checkpoint activation. ULK3’s involvement in the abscission checkpoint was dependent upon its kinase 
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activity and its ability to bind ESCRT-III components [108]. Similarly to the spatiotemporal control of ESCRT-III 
localisation described above, ULK3 overexpression drove retention of ESCRT-III components in the Flemming body, 
in a kinase-dependent manner and ESCRT-III subunits that couldn’t be phosphorylated by ULK3 failed to support 
abscission arrest in response to engagement of this checkpoint [108].  These data indicate that ULK3 is a critical 
component of the abscission checkpoint and that its kinase activity, along with that of Aurora B, is important for 
checkpoint activity.   
Engagement of the abscission checkpoint 
Thus the abscission checkpoint can be effected through regulation ESCRT-III – how then, is it engaged? Lagging 
chromosomes have been discussed as a mechanism for engaging an abscission delay, but there are a number of other 
events that are integrated into this checkpoint. Decatenation errors stemming from improper DNA-replication in S-phase 
can lead to ultrafine bridges (UFBs) of single-stranded DNA during anaphase [131]. UFBs fail to be detected beyond 
anaphase, suggesting that they may be resolved as mitosis progresses. Protein Kinase C Epsilon (PKC operates in 
metaphase to help resolve persistent catenation and suppress the formation of these UFBs [132]. A similar situation 
exists in yeast where Topoisomerase-2 or Condensin inactivation results in spindle stabilisation, engagement of the 
NoCut checkpoint in response to chromatin bridges and abscission delays to promote viability after replication stress. 
Strikingly, chromatin forced into the cleavage plane from artificial dicentric chromosomes did not activate NoCut, 
indicating that the nature of the bridged chromatin is key to engagement of this checkpoint [124,133]. Unreplicated 
DNA lesions can be detected in cytokinetic nuclei and replication stress can also trigger abscission arrest through Ataxia 
telangiectasia and Rad3- (ATR) and Checkpoint Kinase 1- (CHK1) mediated engagement of the abscission checkpoint 
[134], indicating that these kinases participate in genome surveillance and mediate mitotic stress-induced abscission 
arrest. In mammalian cells, PKC functions again in the response to chromatin in the cleavage plane, whereby it 
phosphorylates Aurora B to alter its substrate specificity, favouring phosphorylation of Borealin and engagement of the 
abscission checkpoint. Abscission control mediated through PKC and Aurora B can again be bypassed through 
CHMP4C depletion, suggesting again that this ESCRT-III member is a key effector in this process [135].  
A variety of stresses independent of DNA-replication or chromosome segregation can also engage the abscission 
checkpoint. Tension in the intracellular bridge delays abscission and tension release triggers ESCRT-III assembly, 
suggesting a biophysical mechanism exists to retard or accelerate abscission, depending on the physical environment 
sensed by the cells [107]. In the case where division results in daughter cells occupying spatially distinct areas, a delay 
in the final separation until cells are properly placed may assist organisation of tissue morphology [107]. A further stress 
that can impinge upon abscission dynamics is nuclear pore integrity. In recent years, remarkable control over abscission 
timing has been revealed through manipulations that impair proper functioning of the NPC [136]. Inhibiting NPC 
assembly, through expression of a truncated nucleoporin component, or depletion of NUP153 can trigger an Aurora B-
dependent abscission arrest [137]. Again, abscission arrest is dependent upon CHMP4C [106] and defects in NPC 
assembly produce aberrant activation of Aurora B [136], which may inhibit ESCRT-III assembly or function through 
CHMP4C. The mechanism by which impaired assembly of NPCs during mitotic exit results in subsequent impairment 
of ESCRT-III activity during cytokinesis remains unclear, however the involvement of ANCHR [129], ULK3 [108] and 
CDC-Like Kinases (CLKs) [138] in this pathway suggests that these defects are fed into the canonical abscission 
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checkpoint. Whatever the mechanism, it appears that the abscission checkpoint is engaged to ensure cells enter G1 with 
functional NPCs.  
In yeast, a related situation exists whereby malformed NPCs accumulate in the absence of ESCRT-III activity [139]. 
Budding yeast, where this phenomenon was originally observed, display a closed mitosis and divide their duplicated 
genome without needing to disassemble and reassemble their nuclear envelopes. It is possible that the need to continually 
remodel and insert new NPCs without having the luxury of de-novo insertion during open mitosis has forced the adoption 
of this surveillance strategy in these organisms. Again, the exact mechanism of surveillance remains to be established, 
with suggestions that ESCRT-III functions either to extract, or cause budding of these structures into the intermembrane 
space [140]. However, recent data suggesting that ESCRT-III functions in sealing off the nuclear envelope around the 
defective NPCs, aligns the biology of this process with that observed for nuclear envelope sealing in mammalian cells 
[141] and is discussed later.  
It is important to note that there is unexplained variability in the outcome of disrupting the abscission checkpoint, even 
within similar experimental systems. Sustained Aurora B activity was originally observed to stabilise intercellular canals 
and prevent tetraploidisation induced by cleavage furrow regression [109], whereas rendering CHMP4C unresponsive 
to Aurora B phosphorylation allows abscission to proceed unchecked [106]. Aurora B’s role thus seems to be to stabilise 
the midbody and prevent it from being severed during abscission. Indeed, through phosphorylation of the microtubule 
plus-end binding protein End Binding Protein-3 (EB3) on S176, Aurora B can promote midbody stability and prevent 
premature midbody disassembly [142], thus as well as retarding assembly of the abscission machinery, engagement of 
the abscission checkpoint could act to stabilise the intercellular bridge. However, whilst depletion of other components 
of the abscission checkpoint such as ULK3 permits unchecked cytokinesis completion [108], depletion of ANCHR 
[129], or in some systems, CHMP4C [129], causes cleavage furrow regression and multinucleation. It is fair to say that 
we don’t fully understand the consequences of inactivation of the abscission checkpoint and these different outcomes 
need to be better understood. Whilst Aurora B phosphorylation of CHMP4C has been thought to play a major role in 
effecting an abscission checkpoint, the Mitotic Kinesin-Like Protein-1 (MKLP1), itself proposed as a tether between the 
cleavage furrow and the cortex [143], may also be an important regulator of this checkpoint. MKLP1 localises to 
chromatin bridges and is phosphorylated by Aurora B. One function of persistent Aurora B activity may thus be to retain 
anchors between the cleavage furrow and cortex to prevent regression and multinucleation [109]. In this context, it is 
interesting that MKLP1 forms part of the centralspindlin complex (MKLP1/MgcRacGAP), itself responsible for CEP55 
and subsequently ESCRT-III recruitment to the midbody [46,84,86], and which tethers the plasma membrane to the 
intercellular bridge through interaction of MgcRacGAP’s C1 domain with membrane lipids [144]. Further, MKLP1 
itself bound CHMP4C and its depletion interfered with detection of phosphorylated CHMP4C at the midbody, 
suggesting problems in recruitment of CHMP4C, or its phosphorylation in the absence of MKLP1, which may due in 
part to aberrant spindle organisation after MKLP1 depletion [130]. The related kinesin MKLP2 is necessary for 
relocalisation of the Chromosomal Passenger Complex components Aurora B and the Inner Centromere Protein 
(INCENP) from chromatin in anaphase to the central spindle and midbody [145], however, MKLP2 itself appears a 
target of Aurora B. Aurora B-dependent phosphorylation of MKLP2 in a newly identified membrane-binding region 
inhibited abscission and promoted furrow regression [146]. B56-PP2A, a key phosphatase in the regulation of mitotic 
exit, could counter Aurora B’s phosphorylation of MKLP2 to accelerate abscission [146]. These data suggest that the 
interplay between kinase and phosphatase activity, particularly within membrane anchoring regions of these essential 
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cytokinetic motors, may contribute to the differential outcomes (furrow regression versus cytokinesis completion) 
observed when interfering with different components of this checkpoint.  
ESCRT-dependent cytokinesis in animals 
Whilst ESCRTs have a clear role in cytokinesis in mammalian cells and flies and are necessary for division in Archaea, 
they appear dispensable for cytokinesis in a number of organisms such as yeasts and C. elegans. In worms, high 
resolution tomographic approaches investigating the 1st mitotic division in the C. elegans embryo have demonstrated 
that membrane sealing occurs around the midbody after furrow ingression, leading to cytoplasmic separation [147,148], 
a step shown to be independent of ESCRTs [148]. ESCRTs were instead observed to contribute to shedding of the 
midbody ring into the posterior cell [148]. This recent study instead implicated ESCRTs alongside actin and dynamin 
in a membrane remodelling process that also acted to remove membrane from the midzone during cytokinesis, rather 
than the actual process of abscission itself. Indeed, in worms depleted of Tsg101, abscission still occurred, although it 
was delayed [147]. These data suggest an abscission-independent role for ESCRTs in worm cytokinesis. As discussed 
above, in D. melanogaster, ALIX and ESCRT-III are necessary for cytokinetic abscission of germline stem cell bridges 
in-vivo [78,125]. Moreover, in mammals, ESCRT-dependent abscission is specifically inhibited through the expression 
of Testes Expressed-14 (TEX14), a germ-cell specific protein that mimics the GPP motif within TSG101 and ALIX that 
are normally recruited by CEP55 [149]. In this manner, TEX14 expression ensures abscission is disrupted to enable the 
generation of stable intercellular bridges in male germ cells [149], which is necessary for proper spermatogenesis and 
organismal fertility [150,151]. How (and whether) this stabilisation of intercellular bridges through TEX14-dependent 
competition for ESCRT-recruitment is integrated with stabilisation of these bridges through Aurora B engagement 
remains to be established. TEX14 is found in a locus that contributes to the susceptibility for Testicular Germ Cell 
Tumours [152] and it will be important to determine whether control of ESCRT-dependent abscission affects the 
development of germ cell tumours. Moreover, already implicated in control of the cytokinesis checkpoint, cells lacking 
CHMP4C accumulate DNA damage and CHMP4C has been identified recently as a susceptibility locus for ovarian 
cancer [106,153]. It will be important to determine whether CHMP4C acts as a tumour suppressor by regulating the 
abscission checkpoint and controlling ESCRT-III-dependent abscission. These indicate physiologically relevant roles 
for ESCRT-dependent cytokinesis and highlight the cellular and organismal dysfunction that can occur when its normal 
function is compromised.  
ESCRT-III-dependent nuclear envelope sealing 
Accepted roles for ESCRT-III as the cytokinetic abscission machinery have, in recent years, become established. 
However, early reports indicating the presence of CHMPs on mitotic chromatin [57] suggested that additional mitotic 
roles for ESCRT-III may exist. As explained above, the open mitosis performed by metazoans requires disassembly of 
the nuclear envelope at mitotic onset, and reformation in individual daughter cells during mitotic exit. Following 
chromatid separation, individual daughter nuclei are regenerated during anaphase and telophase.  This requires 
disassembly of the mitotic spindle, decondensation of mitotic chromatin and envelopment of daughter nuclei by cellular 
membranes to form a bi-membraned nuclear envelope.  
It was initially suggested that daughter nuclear membranes were formed de-novo from vesicles produced during nuclear 
envelope fragmentation at prophase. However, this theory was developed in X. laevis cell-free extracts, within which, 
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unlike in intact cells, membranes begin in a fragmented state. It is now more widely accepted that the ER is the source 
of nuclear membranes, with contact sites between ER tubules and chromatin observed shortly after anaphase, followed 
by the coating of chromatin with ER membranes [13,154,155]. As cells leave mitosis, membranation of the chromatin 
is driven by interaction of nuclear envelope specific transmembrane proteins with chromatin and chromatin-associated 
factors which provide temporal control over the envelopment process, allowing the flattened cisternal ER sheets to 
envelope the chromatin. In in-vitro reconstitution assays, p47 and p97-dependent fusion events allows sheet expansion 
to accommodate the growing nuclei [156]. These sheets must negotiate spindle microtubules which traverse the nascent 
nuclear envelope, and must themselves be disassembled. Where these sheets meet in three dimensions, they leave a hole 
that is sealed in a topologically specialised process called annular fusion [18,157], allowing generation of a sealed 
nuclear envelope and the re-establishement of nucleo-cytoplasmic compartmentalisation (Figure 2A and Figure 2B).  
In recent years, a startling relocalisation of ESCRT-III to the reforming nuclear envelope has been observed for a brief 
period during mitotic exit [158,159]. ESCRT-III localisation to this organelle occurs prior to reestablishment of the 
lamina, reincorporation of NPC components and reinitiation of nucleocytoplasmic transport, and appears to coincide 
with the completion of annular fusion. Endogenous ESCRT-III components localised transiently, and in a punctate 
manner, to nuclear membranes with high-resolution 3D-electron tomographic and super-resolution approaches revealing 
that these punctae represented assembly at sites of annular fusion [158,159]. Satisfyingly, completion of annular fusion 
by resolving the stalk connecting inner and outer nuclear membranes bears a topologically equivalence to all ESCRT-
III dependent membrane remodelling events. Here, ESCRT-III acts to separate the inner nuclear membrane (INM) and 
outer nuclear membrane (ONM), creating a sealed nuclear envelope [6,7] (Figure 2A – Figure 2C). ESCRT-III assembly 
at sites of annular fusion lasted for only a few minutes, which, whilst brief, is consistent with the timescale of ESCRT-
III assembly during viral budding [104,160] and the terminal phases of cytokinesis [93]. Depletion of ESCRT-III 
components results in the persistence of unsealed holes in the nuclear envelope which led to a breakdown of nucleo-
cytoplasmic compartmentalisation, evidenced by impaired sequestration of Nuclear Localisation Sequence (NLS)-
targeted probes [158,159]. This disruption in nuclear envelope integrity led to the presence of DNA damage foci at sites 
associated with unsealed holes in the nuclear envelope, indicating that ESCRT-III plays an important role in maintaining 
genome stability [159]. This function in closing holes in the nuclear envelope is particularly relevant during constrained 
migration [161-163], where interphase cells employ this machinery to repair ruptures to this organelle and maintain 
cellular viability.  Readers are referred to the excellent review by Piel and colleagues in this issue [164] for further 
discussion of ESCRT function in membrane repair.   
Nuclear envelope reformation around newly segregated chromatin occurs in parallel with the disassembly of spindle 
microtubules which traverse the nuclear envelope. Mechanisms to remove these microtubules remained unclear until 
recently, but the role of ESCRT-III in sealing nuclear membranes provides a route through which this could be 
accomplished. As in cytokinesis, ESCRT-III subunits can recruit the microtubule severing AAA-ATPase, Spastin to 
disassemble these fibres. In the context of nuclear envelope reformation, Spastin recruitment is dependent upon its MIT-
domain and on the presence of IST1 [159]. The significance of this cross-talk between ESCRT-mediated nuclear 
membrane sealing and Spastin-mediated spindle disassembly is apparent as a delay in microtubule recycling is seen in 
ESCRT-III depleted cells, with microtubules remaining attached to the chromatin disc at sites associated with ESCRT-
III foci [159]. 
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Due to the numerous membrane remodelling roles of ESCRT-III in the cell, the machinery must be recruited to its site 
of action by location-specific adaptor proteins. As described, in the case of cytokinesis, ESCRT-III is recruited by the 
CEP55 midbody protein and during viral budding and multivesicular body biogenesis it is recruited by Gag and ESCRT-
0 respectively. In the context of nuclear envelope reformation, the Stenmark laboratory identified that the poorly studied 
ESCRT-III protein, CHMP7, was necessary for ESCRT-III assembly at the nuclear envelope, pointing to a specific role 
for this protein in this specialised process [159]. In addition to CHMP7, the p97-associated factor Ubiquitin Fusion 
Degradation-1-Like (UFD1L) is able to contribute to incorporation of late-acting ESCRT-III components to these sites 
of annular fusion [158]. In-vitro reconstitution assays have implicated Ubiquitin Fusion Degradation-1 (UFD1) and its 
partner, Nuclear Protein Loclaisation-4 (NPL4) in annular fusion [156], but whilst UFD1L can interact with CHMP2A, 
the mechanism by which it stimulates CHMP2A assembly at sites of annular fusion remains unclear.  
CHMP7 is somewhat of a hybrid protein, with a C-terminal CHMP-like domain that resembles other ESCRT-III subunits 
and an N-terminal tandem winged-helix (WH) domain, which resembles well the tandem-WH domain containing, 
ESCRT-II subunits [141,165,166]. In the context of endosomal sorting, ESCRT-II acts to recruit ESCRT-III to 
endosomal membranes [167] through interactions with 3-phosphoionositides [32,36], and recent data suggest that the 
ESCRT-II-like domain of CHMP7 acts similarly to recruit ESCRT-III to cellular membranes – in this case, the ER and 
nuclear envelope.  
In mammalian cells, endogenous CHMP7 localises to the ER [166], which, during mitotic coalescence with the nuclear 
envelope, allows a platform to recruit ESCRT-III to the reforming nuclear envelope. CHMP7’s N-terminus contains an 
evolutionarily conserved stretch of hydrophobic amino acids which function as a membrane anchor to assemble ESCRT-
III at this organelle. Disruption of this membrane anchor renders CHMP7 cytoplasmic and unable to initiate ESCRT-III 
assembly, demonstrating the essential nature of these protein-lipid interactions for closing holes in this organelle. These 
data also indicate that the CHMP-like domain is insufficient for assembling ESCRT-III at sites of annular fusion [166]. 
What, then, may specify recruitment of CHMP7 to sites of annular fusion in the reforming nuclear envelope? Recent 
data from the Frost, Sundquist and Ullman laboratories has implicated the INM protein LEM2 in initiating recruitment 
of ESCRT-III to the nuclear envelope through binding directly to CHMP7 [168]. Assembly of CHMP7, CHMP2A and 
IST1 at the reforming nuclear envelope was found to be dependent upon LEM2 [168]. These data again highlight how 
ESCRT-III acts as a transplantable membrane remodelling machinery that in this case employs co-incidence detection 
[169] of membrane cues and INM proteins such as LEM2 to specify the site of recruitment. Indeed, the co-incidence 
detection of mitotic ER and chromatin-bound INM proteins may impose a spatial constraint upon ESCRT-III assembly 
to restrict it to sites of continuity between INM and ONM (Figure 2C).  
Whilst yeast typically undergo a closed mitosis, they too express a CHMP7 homologue: Chm7 in S. cerevisiae and Cmp7 
in S. pombe, with data suggesting an ER function for this protein [165]. Importantly, whilst these yeast undergo a closed 
mitosis, they must still divide their nuclei and nuclear envelopes in two, which will necessitate a resealing activity – 
whether yeast ESCRTs function in this process remains to be established.  Fission yeast lacking Vps4 exhibit fenestrated, 
morphologically abnormal and poorly sealed nuclear envelopes, which, given their closed mitosis, suggests a more 
global role in nuclear envelope homeostasis for these proteins. Intriguingly, these phenotypes could be suppressed by 
spontaneous loss of function mutations in either Cmp7 or Lem2 [168]. These data indicate that if ESCRT-III can’t be 
 17 
recruited to this organelle, the deleterious consequences of ESCRT-inactivation on nuclear envelope phenotypes are not 
exposed and suggest that alternate mechanisms for sealing the nuclear envelope may operate in this case. 
ESCRT-III-dependent NPC surveillance at the nuclear envelope 
As described earlier, ESCRT-III proteins also act at the nuclear envelope of S. cerevisiae, albeit during interphase. Here, 
they act to survey for mal-assembled, or poorly functioning NPCs, whose existence would lead to a breakdown in 
nucleocytoplasmic compartmentalisation. These NPCs are cleared in a manner requiring ubiquitin and the proteasome, 
and in strains lacking ESCRT-III components, these defective NPCs aggregate into a single focus, deemed the Storage 
of Improperly Assembled NPCs (SINC) compartment. Once more, the LEM-domain-containing INM proteins are 
implicated in this control; Heh2 can bind to early NPC assembly products, and acts to recruit Snf7/CHMP4 and Vps4, 
indicating that ESCRT-III function acts somehow to remove these defective NPCs [139]. Recently, Chm7 has been 
shown to be directly involved in clearing these defective NPCs, being recruited to the anomalous SINC compartment 
through the LEM-domain containing proteins Heh1 and Heh2 [141]. Lusk and colleagues used yeast bearing a 
temperature-sensitive mutation in Nup116 – in this strain, the defective NPCs are thought to become sealed off by new 
nuclear membrane [170], a process that bears topological equivalence to ESCRT-III mediated membrane sealing. Chm7 
maintained the viability of strains bearing compromised NPCs, suggesting that Chm7 and ESCRT-III may act to seal 
fresh nuclear membrane over the mis-functioning NPC, thus preventing it participating in barrier functions [141] (Figure 
5). The defective NPC would now likely be found in a new INM, where established proteostasis mechanisms such as 
the Asi complex or other INM-relevant ER-associated degradation mechanisms [171,172] could act to recycle these 
components. Deleting Chm7 resulted in compartmentalisation breakdown in strains bearing defective NPCs, indicating 
how Chm7 contributes to cellular viability. These data have the potential to rationalise these different ESCRT-III 
functions at the nuclear envelope, and highlight again ESCRT-III’s role as a membrane remodelling machinery.  
It is unclear whether a similar surveillance role exists in mammalian cells, given that they have ample opportunity to 
remodel their NPCs during each mitosis. However, as described above, telling data indicating that NPC mis-assembly 
can signal through Aurora B to the ESCRT-III mediated abscission checkpoint, to impose a temporal delay upon 
cytokinesis, suggests that such a quality control mechanism may exist [136,137]. Entering the next G1 with improper 
control over nucleocytoplasmic compartmentalisation would likely be detrimental for cellular viability, and whether a 
NPC-associated quality control system exists to suppress cytokinetic ESCRT-III assembly remains an exciting area of 
future study.  
A number of important questions regarding ESCRT function on the nuclear envelope remain. We have little 
understanding of the lipid environment necessary for CHMP7 to assemble ESCRT-III and, whilst interaction with LEM-
domain containing proteins is important, we don’t fully understand how ESCRT-III assembly is restricted to sites of 
annular fusion in the nuclear envelope subdomain. Interaction with spindle microtubules is likely important, but the 
finding that ESCRT-III operates to repair interphase nuclear envelope ruptures, which likely occur in the absence of 
traversing microtubules, suggests that additional factors may be required. Our understanding of how membrane 
remodelling is coordinated with insertion of NPCs [173] remains unclear and whether NPC surveillance occurs in 
mammalian cells remains an open question. Topologically equivalent membrane remodelling is necessary for a variety 
of viruses such as herpesviruses and large Ribonuclear Protein granules to traverse the nuclear envelope [174]. It is 
tempting to speculate that ESCRT-III is involved in this transport, particularly in budding across the INM into the 
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intermembrane space, as this step appears topologically suited to ESCRT-III function on this organelle. The adaptor 
protein ALIX has been implicated in nuclear envelope transit for the herpesvirus Epstein Barr Virus (EBV), being able 
to interact with the viral protein BFRF1 [175]. Ubiquitin and the ESCRT-associated ubiquitin ligase, ITCH, play roles 
too in the maturation of EBV at the nuclear envelope [176]. ESCRTs had previously been implicated in the secondary 
envelopment of herpesvirus particles [177], however, it remains possible that they too contribute to nuclear envelope 
passage too. The coming years look likely to illuminate much exciting ESCRT biology upon this organelle.  
Unexplored roles for the ESCRT machinery in mitosis 
Mitotic roles for ESCRTs have largely stemmed from their ability to remodel membranes, however, intriguing findings 
suggest that more expansive mitotic roles may be played by these proteins. Prior to its relocalisation to the midbody, 
CEP55, the key recruiter of ESCRT-III, localises to centrosomes [86,87]. VPS4 was similarly reported to localise to 
mitotic centrosomes, suggesting there may well be unexplored functions for ESCRTs on this membrane-less organelle 
[178]. As well as abscission defects, ESCRT-depletion resulted in disruption of the centrosome cycle, with depletion of 
most ESCRT-III members causing fragmentation of centrosomes and the pericentriolar material. Loss of CHMP5 or 
CHMP2A, however, was reported to result in a prevalence of monopolar spindles, suggesting that ESCRTs may regulate 
both accumulation and dispersal of centriolar material. In many cases, defects in mitotic chromosome alignment were 
produced which masked subsequent abscission defects and/or produced morphologically abnormal nuclei [178]. It is not 
currently clear what function ESCRTs are playing on centrosomes and how they regulate the integrity of this organelle. 
Indeed, the nuclear morphology defects observed upon ESCRT suppression, and currently ascribed to segregation errors, 
may instead relate to impaired nuclear envelope biology. However, in S. pombe lacking Vps4, karyokinesis defects were 
observed and the duplicated nuclear envelope-embedded spindle pole bodies failed to separate [168], suggesting the 
involvement of ESCRTs in genome segregation in this system too. These cells displayed extensive karmallae (stacks of 
ER and nuclear envelope membrane that surround the nucleus) and excessive tubular extensions and nuclear envelope 
fenestrations, indicating a breakdown of proper nuclear envelope remodelling in the absence of Vps4 and suggesting 
that control of the nuclear envelope and spindle pole biology is intimately linked [168].  
Concluding Remarks 
The prevalence of ESCRT functions in recent years has taken many by surprise; it truly feels as though ‘ESCRTs are 
everywhere’ [9]. However, the topological similarities between all ESCRT-III regulated events point to the evolutionary 
conservation of these proteins as a specific membrane remodelling machinery that is deployed to various cellular 
membranes to effect completion of a biological process. The degree of involvement of ESCRT-III in mitotic membrane 
remodelling events is striking and its evolutionary conservation as far back as Archaea suggests that mitotic functions 
were the ancestral role of this machinery that has been co-opted throughout evolution to effect completion of a variety 
of cell biological processes. These processes all require the resolution of a cytoplasm filled stalk connecting two 
membranes, with ESCRT-III acting to sever of this stalk. Telling cartoons hypothesise the narrowing of an ESCRT-III 
spiral filament bringing the walls of these stalks closer together until wall-fusion becomes inevitable, but it would be 
prudent to remember that we have very little idea of how the membrane fission reaction actually occurs. We do know 
that ESCRT-III acts to separate membranes previously tethered by stalks (intraluminal vesicle and endosomal limiting 
membranes during ILV biogenesis; viral and plasma membranes during viral release; daughter cell plasma membranes 
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during cytokinesis and the INM and ONM during nuclear envelope repair and reformation). It is hoped that biophysical 
lines of enquiry will soon shed light on the mechanics by which these membrane fission reactions are performed.  
Mitotic biology relies upon proper completion of precisely temporally coordinated events, and the surprising 
involvement of ESCRTs in a wealth of mitotic processes will hopefully provide routes by which regulation and 
activation of ESCRT activity can be explored. Documented roles for ESCRTs in nuclear envelope biology and 
cytokinesis have been established, although whether these processes are linked by co-regulatory mechanisms remain 
unclear. For example, it will be important to discover if deregulated ESCRT biology at the nuclear envelope engages 
the abscission checkpoint, or, for example, whether there is coordination between nuclear envelope sealing on lagging 
chromosomes and engagement of this checkpoint. For nuclear envelope-relevant ESCRT-function, it will also be 
important to examine how membrane sealing is coordinated with functionalisation of this organelle through re-
establishment of NPC function and regeneration of INM and ONM identity, and to understand further the evolutionary 
conservation of this function. Regards cytokinesis, a scaling problem between the staging of ESCRT-III at the relatively 
large midbody ring and its eventual transition to the abscission site needs to be understood, as does the relatively 
unexplored process of midbody maturation. Moreover, the apparent absence of involvement of ESCRTs in abscission 
in yeast or C. elegans leads us to question how these species complete cytokinesis.  These are exciting times for ESCRT-
biology and it is hoped that our deeper understanding of roles for this machinery in cell division will illuminate the 
workings of fundamental cellular processes that are essential for life, growth and development. 
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Figures legends 
Figure 1: Topological equivalence of membrane ESCRT-dependent membrane remodelling events 
ESCRT-III is a membrane fission machinery that regulates a series of topologically equivalent membrane remodelling 
events, namely biogenesis of intraluminal vesicles on a class of late endosomes called multivesicular bodies (1), release 
of enveloped retroviruses such as HIV-1 (2), repair of damaged plasma membrane (3), abscission during cytokinesis (4), 
sealing of holes in the nuclear envelope (5), depolymerisation of spindle microtubules (6) and neuronal pruning (7). In 
addition, ESCRT-III has also been described to regulate NPC quality in S. cerevisiae (not depicted; see Figure 5). Sites 
of ESCRT-III activity indicated by magenta asterisks. Sealing of nuclear envelope allows nuclear compartmentalisation, 
indicated in orange.  
Figure 2: Roles for ESCRT-III in membrane remodelling during division 
A. Membrane remodelling events during mitosis. As cells complete division, daughter nuclei are enclosed by sheets of 
ER to generate the nuclear envelope. Where these sheets meet in three dimensions, and where these sheets negotiate 
spindle microtubules, they leave small holes that are sealed by ESCRT-III dependent annular fusion. Completion of 
annular fusion permits nuclear compartmentalisation (indicated by nucleoplasm depicted in orange). Nuclear envelope 
regeneration happens concurrently with ingression of a cleavage furrow between daughter nuclei, leaving cells 
connected by a thin tube of membrane and compressed spindle microtubules, called the midbody. The midbody is 
severed through ESCRT-III-dependent abscission. B. Toplogical equivalence and consequences of ESCRT-III function 
during ESCRT-III-dependent membrane remodelling during mitotic events. C. Molecular interactions that govern 
ESCRT-III assembly at the midbody and at the reforming nuclear envelope. CEP55 recruits ESCRT-III to the midbody 
via either ALIX or ESCRT-I/ESCRT-II. ESCRT-III coordination of the microtubule severing enzyme spastin permits 
disassembly of midbody microtubules. CHMP7 initiates assembly of ESCRT-III at sites of annular fusion through 
engagement of ER-membranes and the chromatin-binding INM protein LEM2. ESCRT-III coordination of the 
microtubule severing enzyme spastin permits disassembly of spindle microtubules.  
Figure 3: Morphological changes during midbody maturation 
The midbody tethers daughter cells at the end of division, and upstream ESCRT-I and ALIX components assemble at 
the Flemming body. Prior to abscission, ESCRT-III components assemble in two rings either side of the Flemming body. 
Rab11-FIP3 positive vesicles and delivery of the actin remodelling proteins p50RhoGAP, SCAMP2/3, OCRL, and 
MICAL1 are necessary to remodel the actin cytoskeleton and form a secondary ingression that narrows the midbody to 
permit subsequent ESCRT-III assembly at the site of abscission. Again, ESCRT-III coordination of Spastin assists in 
disassembling the midbody microtubules, thus coordinating membrane and cytoskeletal remodelling.  
Figure 4: Role of ESCRT-III in the Aurora B mediated abscission checkpoint.  
Cartoon depicting triggers that initiate Aurora B-dependent abscission arrest. Elevated Aurora B downstream of 
chromosome segregation errors or NPC assembly defects (NPC in red, with indicated compartmentalisation breakdown, 
as per [179]) act to retard ESCRT-III-dependent abscission. Whilst a direct target of Aurora B is CHMP4C, ANCHR 
and ULK3 contribute to maintenance of this checkpoint. This checkpoint appears effected by spatiotemporal control 
over ESCRT-III assembly within the midbody; Aurora B phosphorylation directs CHMP4C to the Flemming body and 
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ULK3 also drives ESCRT-III components onto the Flemming body. ANCHR acts to restrict VPS4 to the Flemming 
body and prevents it relocalising to the secondary ingression. Tension in the midbody can act to suppress ESCRT-III-
assembly at the midbody and ESCRT-III-dependent abscission and this signalling acts though ULK3.    
Figure 5:  Potential role for Chm7 and Heh2 in surveillance of damaged NPCs.  
Mis-assembled NPCs are cleared in an ESCRT-III and proteasome dependent manner. In one model of misassembly, 
NPCs lacking Nup116 are encapsulated by new membrane to seal them off and prevent them participating in 
nucleocytoplasmic transport. The N-terminal domain of the INM LEM-domain protein Heh2 interacts with both Snf7 
and the CHMP-like C-terminus of Chm7 and may play a role in this, from an ESCRT-III perspective, topologically 
satisfying closure. Hypothesis and figure drawn and adapted from [141,170].  
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Table 1 
Gene names of ESCRTs from the organisms discussed in this review. Aliases, typically used in mammalian systems, 
are provided. Fly and worm orthologues compiled from Flybase beta (FB2017_93) and Wormbase WS259. Where 
orthologues were predicted, but not annotated, sequence identifiers were used. Usp-50 and Ego-2’s equivalence to UBPY 
and PTPN23 was from [180]. 
 
  
S. 
cerevisiae H. sapiens C. elegans D. melanogaster   Aliases 
ESCRT-0 Vps27 HGS hgrs-1 Hrs  HRS 
 Hse1 STAM1/STAM2 stam-1 Stam   
       
ESCRT-I Vps23 TSG101 tsg-101 Tsg101   
 Vps28 VPS28 vps-28 Vps28   
 Vps37 VPS37A/VPS37B/VPS37C/VPS37D vps-37 Vsp37a/Vps37b   
 Mvb12 UBAP/MVB12A/MVB12B mvb-12 Mvb12   
       
ESCRT-II Vps25 VPS25 vps-25 Vps25  EAP20 
 Vps22 VPS22 vps-22 Vps22/Larsen (Lsn)  EAP30 
 Vps36 VPS36 vps-36 Vps36  EAP45 
       
ESCRT-III Did2/Vps46 CHMP1A/CHMP1B did-2 Chmp1   
 Vps2 CHMP2A/CHMP2B vps-2 Chmp2b   
 Vps24 CHMP3 vps-24 Vps24   
 Snf7 CHMP4A/CHMP4B/CHMP4C vps-32 shrub   
 Vps60 CHMP5 vps-60 Vps60   
 Vps20 CHMP6 vps-20 Vps20   
 Chm7 CHMP7 T24B8.2 CG5498   
 Ist1 IST1 istr-1 CG10103   
       
ESCRT Bro1 PDCD6IP/PTPN23 alx-1/ego-2 ALiX  
ALIX/HD-
PTP 
Associated Doa4 UBPY/STAMBP usp-50 Usp8/CG2224  UBPY/AMSH 
 Vta1 VTA1 T23G11.7 Vta1  LIP5 
 Vps4 VPS4A/VPS4B vps-4 Vps4  
SKD1 
(VPS4B) 
  SPAST spas-1 Spastin  Spastin 
  CC2D1A/CC2D1B Y37H9A.3 
Lethal (2) Giant Discs 
(Lgd)   
  MITD1 Y66D12A.10 CG14985   
 
